ArticleBMC cancer2026

Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study.

Xiaolong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.